Trial NCT00326911

View at ClinicalTrials.gov 
Org. Study IDs: CP02-0555

Last trial update was posted on 2011-05-25

MeSH Interventions

Bevacizumab Cetuximab Gemcitabine

MeSH Conditions

Pancreatic Neoplasms

Other Conditions

Metastatic Pancreatic Cancer

Stopping Reasons

The planned enrollment was 130 patients and the study was halted prematurely due to lack of efficacy in both arms. Enrolled patients continued treatment.

Limitations And Caveats

Accrual on the trial was stopped earlier than planned due to insufficient efficacy in both arms.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID